TLR2 and neoplasm: Combining the TLR2 Ab and chemotherapeutic agent GC significantly improved the therapeutic efficacy of treating the pulmonary metastasis of B16 cells and the survival rate of tumor-bearing mice compared to mice treated with GC alone (P<0.001, Fig. 3B).